{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T18:27:37Z","timestamp":1793125657882,"version":"4.5.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T00:00:00Z","timestamp":1694476800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T00:00:00Z","timestamp":1694476800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100009553","name":"Agentura Pro Zdravotnick\u00fd V\u00fdzkum \u010cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["NV18-06-00417"],"award-info":[{"award-number":["NV18-06-00417"]}],"id":[{"id":"10.13039\/501100009553","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intensive Care Med"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1007\/s00134-023-07208-3","type":"journal-article","created":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T03:02:12Z","timestamp":1694487732000},"page":"1283-1292","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Propafenone versus amiodarone for supraventricular arrhythmias in septic shock: a randomised controlled trial"],"prefix":"10.1007","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1864-2143","authenticated-orcid":false,"given":"Martin","family":"Balik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Maly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Brozek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Rulisek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Porizka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Sachl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Otahal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Brestovansky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Svobodova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Flaksa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zdenek","family":"Stach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Horejsek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Volny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana","family":"Jurisinova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Novotny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"Trachta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Kunstyr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Kopecky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Tencer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaroslav","family":"Pazout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Belohlavek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frantisek","family":"Duska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adela","family":"Krajcova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Waldauf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,12]]},"reference":[{"key":"7208_CR1","volume":"2014","author":"M Arrigo","year":"2014","unstructured":"Arrigo M, Bettex D, Rudiger A (2014) Management of atrial fibrillation in critically ill patients. Crit Care Res Prac 2014:840615","journal-title":"Crit Care Res Prac"},{"key":"7208_CR2","doi-asserted-by":"crossref","unstructured":"Klein Klouwenberg PM FJ, Kuipers S, Ong DS, Peelen LM, van Vught LA, Schultz MJ, van der Poll T, Bonten MJ, Cremer OL, MARS Consortium (2016) Incidence, predictors and outcomes of new-onset atrial fibrillation in critically ill patients with sepsis: a cohort study. Am J Respir Crit Care Med","DOI":"10.1164\/rccm.201603-0618OC"},{"key":"7208_CR3","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1186\/s13054-014-0688-5","volume":"18","author":"S Kuipers","year":"2014","unstructured":"Kuipers S, Klein Klouwenberg P, Cremer OL (2014) Incidence, risk factors and outcomes of new-onset atrial fibrillation in patients with sepsis: a systematic review. Crit Care 18:688","journal-title":"Crit Care"},{"key":"7208_CR4","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.1097\/CCM.0000000000001257","volume":"43","author":"M Arrigo","year":"2015","unstructured":"Arrigo M, Jaeger N, Seifert B, Spahn DR, Bettex D, Rudiger A (2015) Disappointing success of electrical cardioversion for new-onset atrial fibrillation in cardiosurgical ICU patients. Crit Care Med 43:2354\u20132359","journal-title":"Crit Care Med"},{"key":"7208_CR5","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jcrc.2017.04.027","volume":"41","author":"M Balik","year":"2017","unstructured":"Balik M, Kolnikova I, Maly M, Waldauf P, Tavazzi G, Kristof J (2017) Propafenone for supraventricular arrhythmias in septic shock-Comparison to amiodarone and metoprolol. J Crit Care 41:16\u201323","journal-title":"J Crit Care"},{"key":"7208_CR6","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-034774","volume":"10","author":"LJ O'Bryan","year":"2020","unstructured":"O\u2019Bryan LJ, Redfern OC, Bedford J, Petrinic T, Young JD, Watkinson PJ (2020) Managing new-onset atrial fibrillation in critically ill patients: a systematic narrative review. BMJ Open 10:e034774","journal-title":"BMJ Open"},{"key":"7208_CR7","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.amjcard.2014.11.005","volume":"115","author":"NM Allen LaPointe","year":"2015","unstructured":"Allen LaPointe NM, Dai D, Thomas L, Piccini JP, Peterson ED, Al-Khatib SM (2015) Antiarrhythmic drug use in patients <65 years with atrial fibrillation and without structural heart disease. Am J Cardiol 115:316\u2013322","journal-title":"Am J Cardiol"},{"key":"7208_CR8","doi-asserted-by":"publisher","first-page":"419","DOI":"10.5603\/AIT.a2017.0061","volume":"49","author":"M Balik","year":"2017","unstructured":"Balik M, Matousek V, Maly M, Brozek T (2017) Management of arrhythmia in sepsis and septic shock. Anaesthesiol Intensive Ther 49:419\u2013429","journal-title":"Anaesthesiol Intensive Ther"},{"key":"7208_CR9","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"G Hindricks","year":"2021","unstructured":"Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomstr\u00f6m-Lundqvist C, Boriani G, Castella M, Dan GA, Dilaveris PE, Fauchier L, Filippatos G, Kalman JM, La Meir M, Lane DA, Lebeau JP, Lettino M, Lip GYH, Pinto FJ, Thomas GN, Valgimigli M, Van Gelder IC, Van Putte BP, Watkins CL (2021) 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J 42:373\u2013498","journal-title":"Eur Heart J"},{"key":"7208_CR10","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1111\/aas.14007","volume":"66","author":"M Wetterslev","year":"2022","unstructured":"Wetterslev M, M\u00f8ller MH, Granholm A, Hassager C, Haase N, Aslam TN, Shen J, Young PJ, Aneman A, H\u00e4stbacka J, Siegemund M, Cronhjort M, Lindqvist E, Myatra SN, Kalvit K, Arabi YM, Szczeklik W, Sigurdsson MI, Balik M, Keus F, Perner A (2022) Management of acute atrial fibrillation in the intensive care unit: an international survey. Acta Anaesthesiol Scand 66:375\u2013385","journal-title":"Acta Anaesthesiol Scand"},{"key":"7208_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0197352","volume":"13","author":"HB Gwag","year":"2018","unstructured":"Gwag HB, Chun KJ, Hwang JK, Park SJ, Kim JS, Park KM, On YK (2018) Which antiarrhythmic drug to choose after electrical cardioversion: a study on non-valvular atrial fibrillation patients. PLoS ONE 13:e0197352","journal-title":"PLoS ONE"},{"key":"7208_CR12","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","volume":"37","author":"P Kirchhof","year":"2016","unstructured":"Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, Castella M, Diener HC, Heidbuchel H, Hendriks J, Hindricks G, Manolis AS, Oldgren J, Popescu BA, Schotten U, Van Putte B, Vardas P (2016) 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 37:2893\u20132962","journal-title":"Eur Heart J"},{"key":"7208_CR13","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1056\/NEJM199103213241201","volume":"324","author":"DSLP Echt","year":"1991","unstructured":"Echt DSLP, Mitchell LB, Peters RW, Obias-Manno D, Barker AH, Arensberg D, Baker A, Friedman L, Greene HL et al (1991) Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. NEJM 324:781\u2013788","journal-title":"NEJM"},{"key":"7208_CR14","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S0735-1097(02)02705-5","volume":"41","author":"PD-DA Chevalier","year":"2003","unstructured":"Chevalier PD-DA, Burri H, Cucherat M, Kirkorian G, Touboul P (2003) Amiodarone versus placebo and class Ic drugs for cardioversion of recent-onset atrial fibrillation: a meta-analysis. J Am Coll Cardiol 41:255\u2013262","journal-title":"J Am Coll Cardiol"},{"key":"7208_CR15","doi-asserted-by":"publisher","first-page":"203","DOI":"10.5603\/CJ.2013.0035","volume":"20","author":"PYSF Courand","year":"2013","unstructured":"Courand PYSF, Ranc S, Mullier A, Kirkorian G, Bonnefoy E (2013) Arrhythmogenic effect of flecainide toxicity. Cardiol J 20:203\u2013205","journal-title":"Cardiol J"},{"key":"7208_CR16","first-page":"1855","volume-title":"Irwin RS","author":"J Varon","year":"2008","unstructured":"Varon J, Marik PE (2008) Irwin and Rippe\u2019s intensive care medicine. In: Rippe JM (ed) Irwin RS. Wolters Kluwer Health\/Lippincott Williams & Wilkins, Philadelphia, pp 1855\u20131869"},{"key":"7208_CR17","unstructured":"Ganetsky M (2008) Antiarythmic agents. In: Irwin RS (ed) Intensive care medicine. Wolters Kluwer\/Lippincott, Williams & Wilkins, Philadelphia, pp 1486\u20131498"},{"key":"7208_CR18","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1093\/europace\/euv195","volume":"18","author":"K Stoschitzky","year":"2016","unstructured":"Stoschitzky K, Stoschitzky G, Lercher P, Brussee H, Lamprecht G, Lindner W (2016) Propafenone shows class Ic and class II antiarrhythmic effects. Europace 18:568\u2013571","journal-title":"Europace"},{"key":"7208_CR19","doi-asserted-by":"crossref","unstructured":"Lafuente-Lafuente C, Valembois L, Bergmann JF, Belmin J (2015) Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation. Cochrane Database Syst Rev Cd005049","DOI":"10.1002\/14651858.CD005049.pub4"},{"key":"7208_CR20","first-page":"Cd005049","volume":"9","author":"L Valembois","year":"2019","unstructured":"Valembois L, Audureau E, Takeda A, Jarzebowski W, Belmin J, Lafuente-Lafuente C (2019) Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation. Cochrane Database Syst Rev 9:Cd005049","journal-title":"Cochrane Database Syst Rev"},{"key":"7208_CR21","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-031678","volume":"9","author":"M Balik","year":"2019","unstructured":"Balik M, Waldauf P, Maly M, Matousek V, Brozek T, Rulisek J, Porizka M, Sachl R, Otahal M, Brestovansky P, Svobodova E, Flaksa M, Stach Z, Pazout J, Duska F, Smid O, Stritesky M (2019) Efficacy and safety of 1C class antiarrhythmic agent (propafenone) for supraventricular arrhythmias in septic shock compared to amiodarone: protocol of a prospective randomised double-blind study. BMJ Open 9:e031678","journal-title":"BMJ Open"},{"key":"7208_CR22","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"MDC Singer","year":"2016","unstructured":"Singer MDC, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, Hotchkiss RS, Levy MM, Marshall JC, Martin GS, Opal SM, Rubenfeld GD, van der Poll T, Vincent JL, Angus DC (2016) The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315:801\u2013810","journal-title":"JAMA"},{"key":"7208_CR23","unstructured":"Team RC (2022) A language and environment for statistical computing"},{"key":"7208_CR24","unstructured":"Team P (2022) RStudio: integrated development environment for R. Posit Software"},{"key":"7208_CR25","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1007\/s11739-016-1497-4","volume":"12","author":"A Bonora","year":"2017","unstructured":"Bonora A, Turcato G, Franchi E, Taioli G, Dilda A, Zerman G, Maccagnani A, Pistorelli C, Olivieri O (2017) Efficacy and safety in pharmacological cardioversion of recent-onset atrial fibrillation: a propensity score matching to compare amiodarone vs class IC antiarrhythmic drugs. Intern Emerg Med 12:853\u2013859","journal-title":"Intern Emerg Med"},{"key":"7208_CR26","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1016\/0735-1097(94)90652-1","volume":"23","author":"WJ Manning","year":"1994","unstructured":"Manning WJ, Silverman DI, Katz SE, Riley MF, Come PC, Doherty RM, Munson JT, Douglas PS (1994) Impaired left atrial mechanical function after cardioversion: relation to the duration of atrial fibrillation. J Am Coll Cardiol 23:1535\u20131540","journal-title":"J Am Coll Cardiol"},{"key":"7208_CR27","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1159\/000113424","volume":"111","author":"I Grundvold","year":"2008","unstructured":"Grundvold I, Tveit A, Smith P, Seljeflot I, Abdelnoor M, Arnesen H (2008) The predictive value of transthoracic echocardiographic variables for sinus rhythm maintenance after electrical cardioversion of atrial fibrillation. Results from the CAPRAF study, a prospective, randomized, placebo-controlled study. Cardiology 111:30\u201335","journal-title":"Cardiology"},{"key":"7208_CR28","first-page":"821","volume-title":"The practice of clinical echocardiography","author":"C Otto","year":"2012","unstructured":"Otto C (2012) The role of echocardiography in atrial fibrillation and flutter. In: Otto C (ed) The practice of clinical echocardiography. Elsevier Health Sciences, Philadelphia, pp 821\u2013827"},{"key":"7208_CR29","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1007\/s00508-012-0209-y","volume":"124","author":"M Balik","year":"2012","unstructured":"Balik M, Rulisek J, Leden P, Zakharchenko M, Otahal M, Bartakova H, Korinek J (2012) Concomitant use of beta-1 adrenoreceptor blocker and norepinephrine in patients with septic shock. Wien Klin Wochenschr 124:552\u2013556","journal-title":"Wien Klin Wochenschr"},{"key":"7208_CR30","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1001\/jama.2013.278477","volume":"310","author":"A Morelli","year":"2013","unstructured":"Morelli A, Ertmer C, Westphal M, Rehberg S, Kampmeier T, Ligges S, Orecchioni A, D\u2019Egidio A, D\u2019Ippoliti F, Raffone C, Venditti M, Guarracino F, Girardis M, Tritapepe L, Pietropaoli P, Mebazaa A, Singer M (2013) Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial. JAMA 310:1683\u20131691","journal-title":"JAMA"},{"key":"7208_CR31","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1056\/NEJMoa021328","volume":"347","author":"DG Wyse","year":"2002","unstructured":"Wyse DG, Waldo AL, DiMarco JP, Domanski MJ, Rosenberg Y, Schron EB, Kellen JC, Greene HL, Mickel MC, Dalquist JE, Corley SD (2002) A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 347:1825\u20131833","journal-title":"N Engl J Med"},{"key":"7208_CR32","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1056\/NEJMoa1602002","volume":"374","author":"AM Gillinov","year":"2016","unstructured":"Gillinov AM, Bagiella E, Moskowitz AJ, Raiten JM, Groh MA, Bowdish ME, Ailawadi G, Kirkwood KA, Perrault LP, Parides MK, Smith RL 2nd, Kern JA, Dussault G, Hackmann AE, Jeffries NO, Miller MA, Taddei-Peters WC, Rose EA, Weisel RD, Williams DL, Mangusan RF, Argenziano M, Moquete EG, O\u2019Sullivan KL, Pellerin M, Shah KJ, Gammie JS, Mayer ML, Voisine P, Gelijns AC, O\u2019Gara PT, Mack MJ (2016) Rate control versus rhythm control for atrial fibrillation after cardiac surgery. N Engl J Med 374:1911\u20131921","journal-title":"N Engl J Med"},{"key":"7208_CR33","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1056\/NEJMoa021375","volume":"347","author":"IC Van Gelder","year":"2002","unstructured":"Van Gelder IC, Hagens VE, Bosker HA, Kingma JH, Kamp O, Kingma T, Said SA, Darmanata JI, Timmermans AJ, Tijssen JG, Crijns HJ (2002) A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 347:1834\u20131840","journal-title":"N Engl J Med"},{"key":"7208_CR34","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1007\/s00134-016-4407-3","volume":"42","author":"AS McLean","year":"2016","unstructured":"McLean AS, Taccone FS, Vieillard-Baron A (2016) Beta-blockers in septic shock to optimize hemodynamics? No. Intensive Care Med 42:1610\u20131612","journal-title":"Intensive Care Med"},{"key":"7208_CR35","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1001\/jama.2018.4528","volume":"319","author":"WF McIntyre","year":"2018","unstructured":"McIntyre WF, Um KJ, Alhazzani W, Lengyel AP, Hajjar L, Gordon AC, Lamontagne F, Healey JS, Whitlock RP, Belley-C\u00f4t\u00e9 EP (2018) Association of vasopressin plus catecholamine vasopressors vs catecholamines alone with atrial fibrillation in patients with distributive shock: a systematic review and meta-analysis. JAMA 319:1889\u20131900","journal-title":"JAMA"},{"key":"7208_CR36","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.ijcard.2018.04.078","volume":"266","author":"M Balik","year":"2018","unstructured":"Balik M (2018) New-onset atrial fibrillation in critically ill patients\u2014implications for rhythm rather than rate control therapy? Int J Cardiol 266:147\u2013148","journal-title":"Int J Cardiol"},{"key":"7208_CR37","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1097\/CCM.0000000000002512","volume":"45","author":"SA Sterling","year":"2017","unstructured":"Sterling SA, Puskarich MA, Glass AF, Guirgis F, Jones AE (2017) The impact of the sepsis-3 septic shock definition on previously defined septic shock patients. Crit Care Med 45:1436\u20131442","journal-title":"Crit Care Med"},{"key":"7208_CR38","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1097\/01.CCM.0000050454.01978.3B","volume":"31","author":"MM Levy","year":"2003","unstructured":"Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G (2003) 2001 SCCM\/ESICM\/ACCP\/ATS\/SIS international sepsis definitions conference. Crit Care Med 31:1250\u20131256","journal-title":"Crit Care Med"}],"container-title":["Intensive Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-023-07208-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00134-023-07208-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-023-07208-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T04:02:45Z","timestamp":1698897765000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00134-023-07208-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,12]]},"references-count":38,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["7208"],"URL":"https:\/\/doi.org\/10.1007\/s00134-023-07208-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2957601\/v1","asserted-by":"object"}]},"ISSN":["0342-4642","1432-1238"],"issn-type":[{"value":"0342-4642","type":"print"},{"value":"1432-1238","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,12]]},"assertion":[{"value":"19 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}